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 My research was focused on understanding the importance of mammalian RAD51 
paralogs in genome maintenance and suppression of tumorigenesis. The investigation carried 
out during this study has been addressed toward gaining more insights into the involvement 
of RAD51 paralogs in DNA damage signalling, repair of various types of lesions including 
double stranded breaks (DSBs), daughter strand gaps (DSGs), interstrand crosslinks (ICLs), 
and in the protection of stalled replication forks. My study highlights the molecular functions 
of RAD51 paralogs in Fanconi anemia (FA) pathway of ICL repair, in the ATM and ATR 
mediated DNA damage responses, in homologous recombination (HR), and in the recovery 
from replication associated lesions. My research also focused on the development of a novel 
photoinducible ICL agent for targeted cancer therapy. The thesis has been divided into 
following sections as follows: 
Chapter I: General introduction that describes about DNA damage responses and the 
known functions of RAD51 paralogs across species in DNA repair and checkpoint  
The genome of every living organism is susceptible to various types of DNA damage 
and mammalian cells are evolved with various DNA damage surveillance mechanisms in 
response to DNA damages. In response to DNA damage, activated checkpoints arrest the cell 
cycle progression transiently and allow the repair of damaged DNA. Upon completion of 
DNA repair, checkpoints are deactivated to resume the normal cell cycle progression. 
Defective DNA damage responses may lead to chromosome instability and tumorigenesis. 
Indeed, genome instability is associated with several genetic disorders, premature ageing and 
various types of cancer in humans. The major cause of chromosome instability is the 
formation of DSBs and DSGs. Both DSBs and DSGs are the most dangerous type of DNA 
lesions that arise endogenously as well as through exogenous sources such as radiations and 
chemicals. Spontaneous DNA damage is due to generation of reactive oxygen species (ROS) 
through normal cellular metabolism. Replication across ROS induced modified bases and 
single strand breaks (SSBs) leads to DSGs and DSBs, respectively. Such DNA lesions need 
to be accurately repaired to maintain the integrity of the genome. 
To understand the various cellular responses that are triggered after different types of 
DNA damage and the possible roles of RAD51 paralogs in these processes, chapter I of the 
thesis has been distributed in to multiple sections as follows: Briefly, the initial portion of the 
chapter provides a glimpse of various types of DNA damage responses and repair pathways 
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to deal with the lesions arising from both endogenous as well as exogenous sources. Owing to 
the vast range of cellular responses and pathways, the following section provides the detailed 
description and mechanisms of various pathways involved in taking care of wide range of 
DNA lesions from SSBs to DSBs. Subsequent section of chapter I provides a comprehensive 
description of maintenance of genome stability at the replication fork and telomeres. 
Germline mutations in the genes that regulate genome integrity cause various genetic 
disorders and cancer. Mutations in ATM, ATR, MRE11, NBS1, BLM and FANC (1-16), 
BRCA1 and BRCA2 that are known to regulate DNA damage signaling, DNA repair and 
genome integrity lead to chromosome instability disorders such as ataxia-telangiectasia, 
ATR-Seckel syndrome, AT-like disorder, Nijmegen breakage syndrome, Bloom syndrome, 
FA, and breast and ovarian cancers respectively. Interestingly, RAD51 paralog mutations are 
reported in patients with FA-like disorder and various types of cancers including breast and 
ovarian cancers. Mono-allelic germline mutations in all RAD51 paralogs are reported to 
cause cancer in addition to the reported cases of FA-like disorder with bi-allelic germline 
mutations in RAD51C and XRCC2. In accordance, the last section of the chapter has been 
dedicated to describe the genetics of breast and ovarian cancers and the known functions of 
tumor suppressors such as BRCA1, BRCA2 and RAD51 paralogs in the protection of 
genome.   
Despite the identification of five RAD51 paralogs nearly two decades ago, the 
molecular mechanism(s) by which RAD51 paralogs regulate HR and genome maintenance 
remain obscure. To gain insights into the molecular mechanisms of RAD51 paralogs in DNA 
damage responses and their link with genetic diseases and cancer, the following objectives 
were laid for my PhD thesis: 
1) To understand the functional role of RAD51 paralog RAD51C in FA pathway of 
ICL repair and DNA damage signalling. 
2) To dissect the ATM/ATR mediated targeting of RAD51 paralog XRCC3 in the 
repair of DSBs and intra S-phase checkpoint. 
3) To uncover the replication restart pathway after transient replication pause and the 
involvement of distinct complexes of RAD51 paralogs in the protection of 
replication forks. 
4) To design photoinducible ICL agent that can be activated by visible light for 
targeted cancer therapy. 
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Chapter II: Distinct roles of FANCO/RAD51C protein in DNA damage signaling and 
repair: Implications for Fanconi anemia and breast cancer susceptibility 
 RAD51C, a RAD51 paralog has been implicated in HR. However, the underlying 
mechanism by which RAD51C regulates HR mediated DNA repair is elusive. In 2010, a 
study identified biallelic mutation in RAD51C leading to FA-like disorder, whereas a second 
study reported  monoallelic mutations in RAD51C associated with increased risk of breast 
and ovarian cancers. However, the role of RAD51C in the FA pathway of DNA cross-link 
repair and as a tumor suppressor remained obscure. To understand the role of RAD51C in FA 
pathway of ICL repair and DNA damage response, we employed genetic, biochemical and 
cell biological approaches to dissect out the functions of RAD51C in genome maintenance.  
In our study, we observed that RAD51C deficiency leads to ICL sensitivity, chromatid-type 
errors, and G2/M accumulation, which are hallmarks of the FA phenotype. We found that 
RAD51C is dispensable for ICL unhooking and FANCD2 monoubiquitination but is essential 
for HR, confirming the downstream role of RAD51C in ICL repair. Furthermore, we 
demonstrated that RAD51C plays a vital role in the HR-mediated repair of DSBs associated 
with replication. Finally, we showed that RAD51C participates in ICL and DSB induced 
DNA damage signaling and controls intra-S-phase checkpoint through CHK2 activation. Our 
analyses with pathological mutants of RAD51C displayed that RAD51C regulates HR and 
DNA damage signaling distinctly. Together, these results unravel the critical role of RAD51C 
in the FA pathway of ICL repair and as a tumor suppressor. 
 
 
Chapter III: ATM- and ATR-mediated phosphorylation of XRCC3 regulates DNA 
double-strand break-induced checkpoint activation and repair 
 The RAD51 paralogs XRCC3 and RAD51C have been implicated in HR and DNA 
damage responses, but the molecular mechanism of their participation in these pathways 
remained obscured. In our study, we showed that an SQ motif serine 225 in XRCC3 is 
phosphorylated by ATR kinase in an ATM signaling pathway. We found that RAD51C in 
CX3 complex but not in BCDX2 complex is essential for XRCC3 phosphorylation, and this 
modification follows end resection and is specific to S and G2 phases. XRCC3 
phosphorylation was found to be required for chromatin loading and stabilization of RAD51 
and HR-mediated repair of DSBs. Notably, in response to DSBs, XRCC3 participates in the 
intra-S-phase checkpoint following its phosphorylation and in the G2/M checkpoint 
independently of its phosphorylation. Strikingly, we found that XRCC3 distinctly regulates 
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recovery of stalled and collapsed replication forks such that phosphorylation was required for 
the HR-mediated recovery of collapsed replication forks but is dispensable for the recovery 
of stalled replication forks. Together, our findings suggest that XRCC3 is a new player in the 
ATM/ATR-induced DNA damage responses to control checkpoint and HR-mediated repair. 
 
Chapter IV: RAD51 paralogs protect stalled forks and mediate replication restart in an 
FA-BRCA independent manner 
 Mammalian RAD51 paralogs RAD51 B, C, D, XRCC2 and XRCC3 are critical for 
genome maintenance. To understand the crucial roles of RAD51 paralogs during 
spontaneously arising DNA damage, we have studied the RAD51 paralogs assembly during 
replication and examined the replication fork stability and its restart. We found that RAD51 
paralogs are enriched onto the S-phase chromatin spontaneously. Interestingly, the number of 
53BP1 nuclear bodies in G1-phase and micro-nucleation which serve as markers for under 
replicated lesions increases after genetic ablation of RAD51C, XRCC2 and XRCC3. 
Furthermore, we showed that RAD51 paralogs are specifically enriched at two major fragile 
sites FRA3B and FRA16D after replication fork stalling.  We found that all five RAD51 
paralogs bind to nascent DNA strands after replication fork stalling and protect the fork. 
Nascent replication tracts created before fork stalling with hydroxyurea degrade in the 
absence of RAD51 paralogs but remain stable in wild-type cells. This function was dependent 
on ATP binding at the walker A motif of RAD51 paralogs. Our results also suggested that 
RAD51 paralogs assemble into BCDX2 complex to prevent generation of DSBs at stalled 
replication forks, thereby safeguarding the pre-assembled replisome from the action of 
nucleases. Strikingly, we showed that RAD51C and XRCC3 in complex with FANCM 
promote the restart of stalled replication forks in an ATP hydrolysis dependent manner. 
Moreover, RAD51C R258H mutation that was identified in FA-like disorder abrogates the 
interaction of RAD51C with FANCM and XRCC3, and prevents fork restart. Thus, assembly 
of RAD51 paralogs in different complexes prevents nucleolytic degradation of stalled 
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Chapter V: Trans-dichlorooxovandium(IV) complex as a potent photoinducible DNA 
interstrand crosslinker for targeted cancer therapy 
 Although DNA ICL agents such as MMC, cisplatin and psoralen are known to serve 
as anticancer drugs, these agents affect normal cells as well. Moreover, tumor resistance to 
these agents has been reported. We have designed and synthesized a novel photoinducible 
DNA crosslinking agent (ICL-2) which is a derivative of oxovanadiumterpyridine complex 
with two chlorides in trans position. We found that ICL-2 can be activated by UV-A and 
visible light to enable DNA ICLs. ICL-2 efficiently activated FA pathway of ICL repair. 
Strikingly, photoinduction of ICL-2 induces prolonged activation of cell cycle checkpoint and 
high degree of cell death in FA pathway defective cells. Moreover, we showed that ICL-2 
specifically targets cells that express pathological RAD51C mutants. Our findings suggest 
that ICL-2 can be potentially used for targeted cancer therapy in patients with gene mutations 
in FA and HR pathway.     
 
 
 
 
 
  
 
